Inactivation of BRCA1, BRCA2 and p53 genes in sporadic ovarian cancer;Inaktivace genů BRCA1, BRCA2 a p53 u sporadického karcinomu vaječníků

Ceska Gynekologie

Volumn 73, Issue 5, 2008, Pages 298-302

  Zikán, Michal ^a   Pohlreich, P ^b   Freitag, P ^a   Janousek M ^a   Pavlista D ^a   Fischerova D ^a   Jancarkova N ^a   Slama J ^a   Pinkavova I ^a   Cibula, D ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

BRCA1; BRCA2; LOH; Ovarian cancer; p53

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ARTICLE; CARCINOMA; FEMALE; GENE EXPRESSION; GENE SILENCING; GENETICS; HETEROZYGOSITY LOSS; HUMAN; MUTATION; OVARY TUMOR; TUMOR SUPPRESSOR GENE;

BRCA1 PROTEIN; BRCA2 PROTEIN; CARCINOMA; FEMALE; GENE EXPRESSION; GENE SILENCING; GENES, P53; HUMANS; LOSS OF HETEROZYGOSITY; MUTATION; OVARIAN NEOPLASMS;

EID: 58849149056     PISSN: 12107832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Chan, K., Ozcelik, H., Cheung, A., et al. Epigenetic factors controlling the BRCA1 and BRCA2 genes in sporadic ovarian cancer. Cancer Res, 2002, 62, p. 4151-4156.
2. Eltabbakh, GH., Belinson, JL., Kennedy, AW., et al. p53 overexpression is not an independent prognostic factor for patients with primary ovarian epithelial cancer. Cancer, 1997, 80, 5, p. 892-898.
3. Esteller, M., Silva, J., Dominguez, G., et al. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst, 2000, 92, 7, p. 564-569.
4. Geisler, J., Rathe, J., Hattermann-Zogg, M., et al. BRCA1 dysfunction is common in ovarian cancer. J Natl Cancer Inst. 2004, 94, p. 61-67.
5. Gras, E., Cortes, J., Diez, O., et al. Loss of heterozygosity on chromosome 13q12-q14, BRCA-2 mutations and lack of BRCA-2 promoter hypermethylation in sporadic epithelial ovarian tumors. Cancer, 2001, 92, p. 787-795.
6. Herod, JJ., Eliopoulos, AG., Warwick, J. The prognostic significance of Bcl-2 and p53 expression in ovarian carcinoma. Cancer Res, 1996, 56, 9, p. 2178-2184.
7. Hilton, J., Geisler, J., Rathe, J., et al. Inactivation of BRCA1 and BRCA2 in ovarian cancer. J Natl Cancer Inst, 2002, 94, p. 1396-1406.
8. Janatova, M., Pohlreich, P., Matous, B. Detection of the most frequent mutations in BRCA1 gene on polyacrylamide gels containing Spreadex Polymer NAB. Neoplasma, 2003, 50, 4, p. 246-250.
9. Janatova, M., Zikan, M., Dundr, P., et al. Novel somatic mutations in the BRCA1 gene in sporadic breast tumors. Hum Mutat, 2005, 25, 3, p. 319.
10. Kupryjanczyk, J., Thor, AD., Beauchamp, R., et al. p53 gene mutations and protein accumulation in human ovarian cancer. Proc Natl Acad Sci, 1993, 90, p. 4961-4965.
11. McCoy, M., Mueller, C., Roskelley, C. The role of the breast cancer susceptibility gene 1 (BRCA1) in sporadic epithelial ovarian cancer. Reprod Biol Endocrin, 2003, 1, p. 72.
12. Miyamoto, K., Fukutomi, T., Asada, K., et al. Promoter hypermethylation and post-transcriptional mechanisms for reduced BRCA1 immunoreactivity in sporadic human breast cancers. Jpn J Clin Oncol, 2002, 32, 3, p. 79-84.
13. Szabo, C., King, MC. Population genetics of BRCA1 and BRCA2. Am J Hum Genet, 1997, 60, p. 1013-1020.
14. Takahashi, H., Chiu, H., Bandera, C., et al. Mutations of the BRCA2 gene in ovarian carcinomas. Cancer Res. 1996, 56, p. 2738-2741.
15. Verma, M., Srivastava, S. Epigenetics in cancer: implications for early detection and prevention. Lancet Oncol, 2002, 3, p. 755-763.
16. Zikan, M., Pohlreich, P., Stribrna, J. Mutational analysis of the BRCA1 gene in 30 Czech ovarian cancer patients. J Genet. 2005, 84, 1, p. 63-67.
17. Zikan, M., Pohlreich, P., Stribrna, J. Novel complex genomic rearrangement of the BRCA1 gene. Mutat Res. 2007 (doi:10.1016/j.mrfmmtn.2007.08. 002).